CompletedNCT02025998
Ibudilast Safety and Initial Effects for Alcohol Use
About this title
Development of Ibudilast for Alcohol Use Disorder
Read the official source — NCT02025998Medication studyAges 21–65United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 21 years to 65 years.
What did participation involve?
The protocol describes two separate seven-day inpatient stays, with ibudilast in one period and placebo (an inactive comparison treatment) in the other. It also includes alcohol given through a vein, stress-exposure procedures and exposure to alcohol-related cues.
- Listed locations
- Los AngelesSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Study information
Study start dateDecember 2013
- Recruitment status
- Completed
- Enrollment listed in the registry
- 24
- Sponsor
- University of California, Los Angeles
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug, Other
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 21 Years to 65 Years
- Official registry ID
- NCT02025998
- Official title
Show the full official title
Development of Ibudilast as a Novel Treatment for Alcohol Dependence
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Los Angeles
Interested in joining this study?
Questions about this study
What did participation involve?
The protocol called for participants to take study medication.
Who is behind this study?
The study sponsor is University of California, Los Angeles, a university.
Did this study involve medication?
Yes. The study involved medication, including Ibudilast.
Who was this study for?
Listed age limits: 21 years to 65 years.
